Advances in immunotherapy is largely responsible for the decline in cancer death rates over the past 20 years. What’s next?

At #AACR26, Carl June, MD (
@carlhjune

@PennCancer
) highlights the future of cellular therapy in solid tumors:
• Precision targeting
• Enhanced